- Mots-clés > access to medicines
- Mots-clés > availability, affordability, and quality of pharmaceutical products
- Mots-clés > Civil Society
- Mots-clés > medicines market
- Mots-clés > Medicines Patent Pool
- Mots-clés > Nongovernmental organizations (NGOs)
- Mots-clés > pharmaceutical market
- Mots-clés > UNITAID (the International Drug Purchasing Facility)
(2009; 8 pages) [Portuguese]
Access to medicines remains a major challenge for people in developing countries. With the right medicines, diseases such as HIV and AIDS, tuberculosis (TB), and malaria are treatable. Yet for millions of poor people, affordable medicines are out of reach.
UNITAID was established in 2006 as a new public health financing mechanism and a South–North collaboration. It is partially funded through an innovative airline tax that ensures stable long-term financing. UNITAID uses this unique feature to intervene in the market to make medicines for HIV, TB, and malaria affordable and available to people in low- and middleincome countries.
Civil society (NGOs and communities affected by the diseases) has two seats with voting rights on the executive board, and plays an important role in influencing UNITAID policies and strategies.
This document aims to encourage more civil society organisations to engage, so that UNITAID benefits from our collective inputs.